University of Missouri School of Medicine MU Health School of Medicine
News Divider

MU Researchers Find Gene Therapy Protects Mice from Heart Condition


The condition is a leading cause of death for those with Duchenne muscular dystrophy

A new gene therapy developed by researchers at the University of Missouri School of Medicine has shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.

Lai

“This is a new therapeutic avenue,” said Yi Lai, PhD, the leading author of the study and assistant research professor in the MU School of Medicine’s Department of Molecular Microbiology and Immunology. “This is just a first step, but we hope this could lead to a treatment for people with this devastating heart condition, which is a leading cause of death for people with Duchenne muscular dystrophy.”

About one in 3,500 children, mostly boys, are born with Duchenne muscular dystrophy (DMD). They experience a progressive wasting away of muscles, starting in the legs and pelvis. Children with DMD have difficulty walking, and most need wheelchairs by age 12.

As DMD depletes the skeletal muscles, it also causes the heart to decay. A weakened heart kills up to 40 percent of people with DMD, usually by their 20s or early 30s. DMD originates with mutations in a single gene. For more than two decades, researchers have explored using gene therapy, an experimental treatment, to replace the flawed gene with a healthy copy.

Duan
Duan

The recent MU study, however, did not try to replace the faulty gene. The researchers targeted a different gene — one involved with the heart’s built-in system for responding to heart attacks and other emergencies.

This targeted gene expresses a protein called nNOS. During short-term stresses, nNOS activates briefly to help regulate the heart. The MU researchers altered the gene to enable more efficient transfer of the nNOS gene to mouse hearts.

Seven months after the gene therapy, the mice who received the treatment showed significantly improved overall heart health. On most disease indicators, the researchers found that the treatment protected their hearts from the damage of DMD.

“The study showed for the first time that a modified nNOS gene could be delivered through gene therapy to protect the hearts of mice from Duchenne muscular dystrophy,” said Dongsheng Duan, PhD, co-author of the study and Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine.

“Since nNOS protects against multiple heart diseases, this method could one day be extended to the treatment of other heart diseases, such as heart failure or a heart attack,” Duan said.

The technique is in an early stage of development and will require more research before potential applications in humans are explored.

The study, “Partial Restoration of Cardiac Function with ∆PDZ nNOS in Aged MDX Model of Duchenne Cardiomyopathy,” was published in June in Human Molecular Genetics. Along with Lai and Duan, other study authors include Junling Zhao, research technician, Yongping Yue, senior research specialist, and Nalinda B. Wasala, graduate student, all of the MU Department of Molecular Microbiology and Immunology.

Click here to download a high resolution portrait of Lai.
Click here to download a high resolution portrait of Duan.

 


MU Health Magazine

Divider

News and Events

Patrice Delafontaine MU School of Medicine Dean Inducted into Prestigious Medical Society
Delafontaine joins elite group of physicians in American Clinical and Climatological Association
Steven Zweig MU Family Medicine Ranked Among Nation’s Best by U.S. News & World Report
Department has been in top 10 for 23 consecutive years
Uzma Khan MU Initiative Helps Rural Doctors Treat Chronic Pain
Show-Me ECHO to offer special training session April 28
Legacy Teachers MU School of Medicine Program Expands to Other Medical Schools
MU’s Legacy Teachers program lets students recognize patients as educators
Susan Nagel Oil and Gas Wastewater Disposal May Increase Endocrine Disrupting Activity
Scientists draw conclusions after study at natural gas and oil extraction wastewater disposal facility
St. Baldricks 2016 Participants Go Bald for Childhood Cancer Research
Community donates more than $40,000 to the cause
Casey Holliday Holliday Recognized for Evolutionary Research
Anatomy researcher receives Young Investigator Award
Diversity and Inclusion Medical Students, Faculty Discuss Diversity, Inclusion
MU School of Medicine hosts gathering at Student National Medical Association annual meeting
Stevermer A Better Fix for Torn ACLs
Study validates newer surgical method for stronger, more natural ligament repair
Stevermer MU School of Medicine Professor to Serve on Elite Medical Society
James Stevermer, MD, to join the Health of the Public and Science Commissions
Khatri Improved Patient Outcomes Linked to Specific Health IT Resources in Hospitals
MU researcher says on-site health IT experts boost employee productivity in hospitals
William Durante Enzyme May Reduce Risk of Cardiovascular Disease Caused by HIV Medications
Study identifies enzyme that may counteract heart problems associated with antivirals
William Durante Enzyme May Reduce Risk of Cardiovascular Disease Caused by HIV Medications
Study identifies enzyme that may counteract heart problems associated with antivirals
Laura Morris Juggling Parenting Roles During Residency Training
Residency programs should include flexible scheduling, daycare, peer-to-peer support, MU researcher says
Match Day 2016 Match Day Brings New Beginnings for Medical Students
One hundred percent of the 2016 class received a residency program match
Fraser Nine Graduates and Supporters of MU School of Medicine to Receive Alumni Awards
Medical School Alumna Victoria Fraser to receive top honor
Sandeep Gautam Improved Imaging Takes X-ray Risks Out of the Picture
Study builds on previous research to show that fluoroless procedures are safer, just as effective
Karla Washington Women Report More Challenges Than Men When Caring for Terminally Ill Loved Ones
MU researcher finds female caretakers experience lower self-esteem, more negative effects



Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Diamond Dixon
DixonDi@health.missouri.edu
(573) 884-7541

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Jennifer Orford
orfordj@health.missouri.edu
(573) 882-0298

Jesslyn Chew
chewj@missouri.edu
(573) 884-2891

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Justin Willett
willettj@health.missouri.edu
(573) 884-7740



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: September 30, 2014 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.